Retatrutide — Escalating
Research-backed ramp: 2 → 4 → 8 → 12 mg weekly over 16 weeks
Dose ladder
- Phase 1 / 4Ramp 1Weeks 1–42 mg
- Phase 2 / 4Ramp 2Weeks 5–84 mg
- Phase 3 / 4Ramp 3Weeks 9–128 mg
- Phase 4 / 4MaintenanceWeek 13+12 mg
What you'll need
Reference defaults for Retatrutide — Escalating. Your provider may set different values — adjust as needed.
- Vial20 mgstarting size
- BAC water2 mlfor reconstitution
- Concentration10.00 mg/mlcomputed
- Duration16+ weeks4 phases
How the app runs this for you
Auto-advance phases
Retatrutide — Escalating ramps automatically week by week — no manual tracking. The current phase and remaining weeks are visible on the home tab and the lock-screen widget.
Smart reminders
Per-protocol notifications fire at your chosen time. Missed-dose detection flags any log >15 minutes late, with one-tap resolve from the lock screen.
Body-map rotation
Each log records the injection site. The body map remembers recency so you don't reuse the same spot — especially important on multi-week protocols.
Side effects to watch for
Common in the GLP-1 category. The iOS app lets you track all of these on a timeline and surfaces patterns as your body adapts.
- Nausea, vomiting, diarrhea, constipation — most pronounced in the first weeks of titration
- Reduced appetite (the intended effect, but watch for muscle loss without protein intake)
- Fatigue, headache, dizziness early in titration
- Rare but serious: pancreatitis, gallbladder issues, severe dehydration
Defaults
- Vial size
- 20 mg
- BAC water
- 2 ml
- Concentration
- 10.00 mg/ml
- Total weeks
- 16+
Uses Retatrutide. Typical dose range: 1–12 mg. Research publications. Not medical advice.
How Retatrutide — Escalating compares to other GLP-1 protocols
5 protocols comparedQuick read of the dose ladders, durations, and concentrations across the glp-1 category.
| Protocol | Peptide | Duration | Phases | Concentration |
|---|---|---|---|---|
| Retatrutide — Escalating | retatrutide | 16+ weeks | 4 | 10.00 mg/ml 20 mg / 2 ml |
| Semaglutide — Standard TitrationPopular | semaglutide | 16+ weeks | 5 | 5.00 mg/ml 10 mg / 2 ml |
| Semaglutide — Gentle Start | semaglutide | 16+ weeks | 3 | 5.00 mg/ml 10 mg / 2 ml |
| Tirzepatide — Standard TitrationPopular | tirzepatide | 20+ weeks | 6 | 15.00 mg/ml 30 mg / 2 ml |
| Tirzepatide — Aggressive | tirzepatide | 12+ weeks | 6 | 15.00 mg/ml 30 mg / 2 ml |
Retatrutide — Escalating FAQ
Answers, not hype.
Retatrutide — Escalating is a 16-week GLP-1 protocol using Retatrutide. Research-backed ramp: 2 → 4 → 8 → 12 mg weekly over 16 weeks
The standard cycle is 16+ weeks across 4 dose phases. Phase 1 (Ramp 1) starts at 2 mg per dose; the final phase (Maintenance) reaches 12 mg. Individual response and provider guidance can extend or shorten the timeline.
Retatrutide — Escalating defaults to a 20 mg vial reconstituted with 2 ml of bacteriostatic water — a concentration of 10.00 mg/ml. The reconstitution calculator on this site lets you adjust to whatever vial size you actually have.
Retatrutide is a research peptide and is not FDA-approved for human use. The Retatrutide — Escalating schedule reflects patterns reported in research literature, not a clinical guideline. Use only under provider supervision.
Most GLP-1 protocols share a common side-effect pattern documented on the parent peptide page. Track them in a timeline view (the iOS app does this automatically) so you can see whether symptoms are settling at the current dose or worsening — that is the signal that determines whether to advance the next phase or hold.
No. Retatrutide — Escalating is a reference template summarizing patterns from authoritative sources. It is not a personalized treatment plan. Talk to a licensed healthcare provider before starting, modifying, or stopping any peptide protocol.
More GLP-1 protocols
Semaglutide — Standard Titration
PopularThe classic 16-week ramp: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly
View protocolSemaglutide — Gentle Start
Slower ramp for sensitive users — 8 weeks at each dose
View protocolTirzepatide — Standard Titration
Popular20-week ramp: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly
View protocolTirzepatide — Aggressive
Faster dose escalation for experienced users — 12 weeks to 15mg
View protocolLiraglutide — Daily Ramp
Daily ramp: 0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg over 5 weeks
View protocol
Run this protocol on autopilot
The iOS app advances this ramp week by week, fires reminders, and keeps a doctor-ready record.
Download on theApp Store